Brief: Biovica Says DiviTum TKa To Pursue Gap-Fill Process For CMS Pricing Decision

Biovica International AB

28/09/2023 11:13

Sept 28 (Reuters) - Biovica International AB
 BIOVICb.ST :
    * DIVITUM TKA TO PURSUE GAP-FILL PROCESS FOR CMS PRICING
DECISION
    * CMS WILL CONSIDER PREVIOUSLY NEGOTIATED RATES WITH PRIVATE
PAYERS AND CHARGES FOR TEST, AND ADDITIONAL FACTORS
    * PROCESS IS EXPECTED TO TAKE AROUND ONE YEAR AND PLA CODE
ALONG
WITH ITS PRICING IS EXPECTED TO BE IMPLEMENTED FROM JANUARY 1,
2025

Source text for Eikon:  ID:nMFNPS8P8 
Further company coverage:  BIOVICb.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;;))